BUSINESS BITES: Sinocare Grows US Biz; Valeritas Finally Goes Public; Cytosystems Nabs EU Grant; B+L, IBM Eye New App
This article was originally published in Clinica
Executive Summary
Sinocare, China’s largest manufacturer of budget-end blood glucose monitoring systems is expanding its presence in the US with the proposed acquisition of Indiana-based PTS Diagnostics. PTS supplies point-of-care biometric testing devices, including the CardioChek family of blood lipid analyzers, A1CNow systems for blood glucose and PTS Detect cotinine systems. Its products are sold entirely through distributors in over 135 countries.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.